Emily Black
Medical · Fort Worth, TXNPI 1407257231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations.
Across 255 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$826
- AbbVie$701
- Johnson & Johnson$538
- Lilly USA, LLC$528
- Sun Pharmaceutical Industries Inc.$480
- Sanofi$445
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,11397%
- Education$1603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $826 |
| AbbVie | 34 | $701 |
| Johnson & Johnson | 28 | $538 |
| Lilly USA, LLC | 24 | $528 |
| Sun Pharmaceutical Industries Inc. | 19 | $480 |
| Sanofi | 28 | $445 |
| Amgen | 7 | $400 |
| UCB, Inc. | 9 | $307 |
| VYNE Pharmaceuticals Inc. | 11 | $276 |
| E.r. Squibb & Sons, L.L.C. | 8 | $228 |
| Dermavant Sciences, Inc. | 7 | $222 |
| Incyte Corporation | 5 | $201 |
| Journey Medical Corporation | 3 | $171 |
| LEO Pharma Inc. | 5 | $152 |
| Almirall LLC | 6 | $132 |
| Mayne Pharma Commercial LLC | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Galderma Laboratories, L.p. | 6 | $113 |
| Pfizer | 5 | $92 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| GSK | 2 | $31 |
| Revance Therapeutics, Inc. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Dermira, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,273 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $100,765 |
| Dupixent PenDupilumab | 13 | $48,617 |
| Doxycycline Hyclate | 13 | $1,371 |
| Tacrolimus | 11 | $962 |
| Triamcinolone Acetonide | 43 | $400 |
| Mupirocin | 18 | $153 |
| Hydrocortisone | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other medical in Fort Worth
- Mark DavisFort Worth$1M
- Francesca FongFort Worth$25K
- Elizabeth WidmerFort Worth$14K
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.